Cas:24248-69-9 2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridine-3-carboxylic acid amide manufacturer & supplier

Chemical Name:2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridine-3-carboxylic acid amide

CAS.NO:24248-69-9

Synonyms:2-amino-6-methyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide;2-Amino-6-methyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide

Molecular Formula:C₉H₁₃N₃OS

Molecular Weight:211.28400

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:100.59000

Exact Mass:211.07800

LogP:1.63650

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-amino-6-methyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-6-methyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-6-methyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide Use and application,2-Amino-6-methyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide technical grade,usp/ep/jp grade.

Related News: Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridine-3-carboxylic acid amide manufacturer For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said. 2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridine-3-carboxylic acid amide supplier Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridine-3-carboxylic acid amide vendor With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. 2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridine-3-carboxylic acid amide factory For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said.